These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 35031226)

  • 41. Oncological Efficacy of Robotic Nephroureterectomy vs. Open and Laparoscopic Nephroureterectomy for Suspected Non-Metastatic UTUC-A Systematic Review and Meta-Analysis.
    Rajan K; Khalifa A; Geraghty R; Parmar K; KandaSwamy G; Gómez Rivas J; Somani B; Rai BP
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: A systematic review and meta-analysis.
    Kim DK; Lee JY; Kim JW; Hah YS; Cho KS
    Crit Rev Oncol Hematol; 2019 Mar; 135():59-65. PubMed ID: 30819447
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of oncological outcomes for hand-assisted and pure laparoscopic radical nephroureterectomy: results from the Taiwan Upper Tract Urothelial Cancer Collaboration Group.
    Yu CC; Chen CH; Hong JH; Ke HL; Li WM; Chung SD; Wu WC; Chen YT; Jiang YH; Lin YH; Lin WY; Wu CC; Tsai YC
    Surg Endosc; 2022 Jun; 36(6):4342-4348. PubMed ID: 34716480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Perioperative and oncologic outcomes of transperitoneal versus retroperitoneal laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma: a systematic review and pooled analysis of comparative outcomes.
    Zhu PY; Wang L; Li KP; Yin S; Chen XB
    World J Surg Oncol; 2023 May; 21(1):163. PubMed ID: 37248555
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review.
    Aziz A; Dobruch J; Hendricksen K; Kluth LA; Necchi A; Noon A; Rink M; Roghmann F; Seiler R; Gontero P; Kassouf W; Shariat SF; Xylinas E;
    World J Urol; 2017 Sep; 35(9):1401-1407. PubMed ID: 28074261
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive model for systemic recurrence following cisplatin-based neoadjuvant chemotherapy and radical nephroureterectomy for high risk upper tract urothelial carcinoma.
    Ghandour RA; Freifeld Y; Cheaib J; Singla N; Meng X; Kenigsberg A; Bagrodia A; Woldu S; Hoffman-Censits J; Enikeev D; Rapoport L; Petros FG; Raman JD; Pierorazio PM; Matin SF; Margulis V
    Urol Oncol; 2021 Nov; 39(11):788.e15-788.e21. PubMed ID: 34330655
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of Variant Histology on Oncological Outcomes in Upper Tract Urothelial Carcinoma: Results From the ROBUUST Collaborative Group.
    Douglawi A; Ghoreifi A; Carbonara U; Yip W; Uzzo RG; Margulis V; Ferro M; Cobelli O; Wu Z; Simone G; Mastroianni R; Rha KH; Eun DD; Reese AC; Porter JR; Derweesh I; Mehrazin R; Rosiello G; Tellini R; Jamil M; Kenigsberg A; Farrow JM; Schrock WP; Cacciamani G; Srivastava A; Bhattu AS; Mottrie A; Gonzalgo ML; Sundaram CP; Abdollah F; Minervini A; Autorino R; Djaladat H
    Clin Genitourin Cancer; 2023 Oct; 21(5):563-568. PubMed ID: 37301663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Miyake M; Tatsumi Y; Matsumoto H; Nagao K; Matsuyama H; Inamoto T; Azuma H; Yasumoto H; Shiina H; Fujimoto K;
    BJU Int; 2018 May; 121(5):764-773. PubMed ID: 29281857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.
    Yuan H; Chen X; Liu L; Yang L; Pu C; Li J; Bai Y; Han P; Wei Q
    Urol Oncol; 2014 Oct; 32(7):989-1002. PubMed ID: 25082191
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Robot-assisted versus open radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: A retrospective cohort study across ten years.
    Zeuschner P; Vollmer SG; Linxweiler J; Wagenpfeil G; Wagenpfeil S; Saar M; Siemer S; Stöckle M; Heinzelbecker J
    Surg Oncol; 2021 Sep; 38():101607. PubMed ID: 34022505
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison between robot-assisted versus open nephroureterectomy for upper tract urothelial carcinoma: outcomes from a pooled analysis.
    Li KP; Chen SY; Wang CY; Wan S; Yang L
    J Robot Surg; 2023 Aug; 17(4):1227-1238. PubMed ID: 36884204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravesical chemotherapy use after radical nephroureterectomy: A national survey of urologic oncologists.
    Lu DD; Boorjian SA; Raman JD
    Urol Oncol; 2017 Mar; 35(3):113.e1-113.e7. PubMed ID: 27884539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Robotic radical nephroureterectomy and segmental ureterectomy for upper tract urothelial carcinoma: a multi-institutional experience.
    Campi R; Cotte J; Sessa F; Seisen T; Tellini R; Amparore D; Mormile N; Gobert A; Mari A; Porpiglia F; Serni S; Minervini A; Rouprêt M
    World J Urol; 2019 Nov; 37(11):2303-2311. PubMed ID: 31062121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma.
    Pradere B; D'Andrea D; Schuettfort VM; Foerster B; Quhal F; Mori K; Abufaraj M; Margulis V; Deuker M; Briganti A; Muilwijk T; Hendricksen K; Lotan Y; Karakiewic P; F Shariat S;
    World J Urol; 2021 Jul; 39(7):2567-2577. PubMed ID: 33067726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer.
    Dominguez-Escrig JL; Peyronnet B; Seisen T; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Gontero P; Lam T; MacLennan S; Mostafid H; Palou J; van Rhijn BWG; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
    Eur Urol Focus; 2019 Mar; 5(2):224-241. PubMed ID: 29158169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in the Perioperative Management and Outcomes of Patients With Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy at Memorial Sloan Kettering Cancer Center: Over 20 Years of Experience.
    Yip W; Assel MJ; Wong NC; Tracey AT; Alvim RG; Nogueira L; Almassi N; Singla N; Clinton TN; Sjoberg DD; Al-Ahmadie H; Hakimi AA; Pietzak EJ; Cha EK; Donahue TF; Dalbagni G; Bochner BH; Bajorin DF; Coleman JA
    Urol Pract; 2024 Mar; 11(2):356-366. PubMed ID: 38315829
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neoadjuvant systemic therapy in patients undergoing nephroureterectomy for urothelial cancer: a multidisciplinary systematic review and critical analysis.
    Wu Z; Li M; Wang L; Paul A; Raman JD; Necchi A; Psutka SP; Buonerba C; Zargar H; Black PC; Derweesh IH; Mir MC; Uzzo RG; Pandolfo SD; Autorino R; DI Lorenzo G
    Minerva Urol Nephrol; 2022 Oct; 74(5):518-527. PubMed ID: 35383431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single-stage Xi® robotic radical nephroureterectomy for upper tract urothelial carcinoma: surgical technique and outcomes.
    Veccia A; Carbonara U; Derweesh I; Mehrazin R; Porter J; Abdollah F; Mazzone E; Sundaram CP; Gonzalgo M; Mastroianni R; Ghoreifi A; Cacciamani GE; Patel D; Marcus J; Danno A; Steward J; Satish Bhattu A; Asghar A; Reese AC; Wu Z; Uzzo RG; Minervini A; Rha KH; Ferro M; Margulis V; Hampton LJ; Simone G; Eun DD; Djaladat H; Mottrie A; Autorino R
    Minerva Urol Nephrol; 2022 Apr; 74(2):233-241. PubMed ID: 33781022
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis.
    Moschini M; Zamboni S; Afferi L; Pradere B; Abufaraj M; Soria F; D'Andrea D; Roupret M; De la Taille A; Simeone C; Mattei A; Mathieu R; Bensalah K; Wirth MP; Montorsi F; Briganti A; Gallina A; Simone G; Gallucci M; Di Bona C; Marra G; Mari A; Di Trapani E; Alvarez Maestro M; Krajewski W; Shariat SF; Xylinas E; Baumeister P
    Arab J Urol; 2020 Sep; 19(1):31-36. PubMed ID: 33763246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes.
    Belhadj Y; Grande P; Seisen T; Gobert A; Gomez FD; Cussenot O; Roupret M
    BJU Int; 2019 Apr; 123(4):618-623. PubMed ID: 30548115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.